These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 36180811)

  • 1. Immunogenic cell death (ICD)-inducers in non-small-cell lung carcinoma (NSCLC): current knowledge and future perspective.
    Kashefizadeh A; Kazemizadeh H
    Clin Transl Oncol; 2023 Feb; 25(2):316-322. PubMed ID: 36180811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stimuli-responsive nanodelivery systems for amplifying immunogenic cell death in cancer immunotherapy.
    Xu W; Liu W; Yang J; Lu J; Zhang H; Ye D
    Immunol Rev; 2024 Jan; 321(1):181-198. PubMed ID: 37403660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rediscovery of nanoparticle-based therapeutics: boosting immunogenic cell death for potential application in cancer immunotherapy.
    Yang S; Sun IC; Hwang HS; Shim MK; Yoon HY; Kim K
    J Mater Chem B; 2021 May; 9(19):3983-4001. PubMed ID: 33909000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promotion of ICD via Nanotechnology.
    Qin Y; Zhang H; Li Y; Xie T; Yan S; Wang J; Qu J; Ouyang F; Lv S; Guo Z; Wei H; Yu CY
    Macromol Biosci; 2023 Sep; 23(9):e2300093. PubMed ID: 37114599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reinforcing the immunogenic cell death to enhance cancer immunotherapy efficacy.
    Yu S; Xiao H; Ma L; Zhang J; Zhang J
    Biochim Biophys Acta Rev Cancer; 2023 Sep; 1878(5):188946. PubMed ID: 37385565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Engineering nanomedicines through boosting immunogenic cell death for improved cancer immunotherapy.
    Gao J; Wang WQ; Pei Q; Lord MS; Yu HJ
    Acta Pharmacol Sin; 2020 Jul; 41(7):986-994. PubMed ID: 32317755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent progress in stimuli-responsive nanosystems for inducing immunogenic cell death.
    Banstola A; Poudel K; Kim JO; Jeong JH; Yook S
    J Control Release; 2021 Sep; 337():505-520. PubMed ID: 34314800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Photothermal MnO
    Chen Z; Zhang Q; Huang Q; Liu Z; Zeng L; Zhang L; Chen X; Song H; Zhang J
    Int J Pharm; 2022 Apr; 617():121578. PubMed ID: 35176333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenic cell death in cancer therapy: Present and emerging inducers.
    Zhou J; Wang G; Chen Y; Wang H; Hua Y; Cai Z
    J Cell Mol Med; 2019 Aug; 23(8):4854-4865. PubMed ID: 31210425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Damage-associated molecular patterns (DAMPs) related to immunogenic cell death are differentially triggered by clinically relevant chemotherapeutics in lung adenocarcinoma cells.
    Solari JIG; Filippi-Chiela E; Pilar ES; Nunes V; Gonzalez EA; Figueiró F; Andrade CF; Klamt F
    BMC Cancer; 2020 May; 20(1):474. PubMed ID: 32456685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microbes mediated immunogenic cell death in cancer immunotherapy.
    Huang J; Duan F; Xie C; Xu J; Zhang Y; Wang Y; Tang YP; Leung EL
    Immunol Rev; 2024 Jan; 321(1):128-142. PubMed ID: 37553793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metal-based anticancer agents as immunogenic cell death inducers: the past, present, and future.
    Sen S; Won M; Levine MS; Noh Y; Sedgwick AC; Kim JS; Sessler JL; Arambula JF
    Chem Soc Rev; 2022 Feb; 51(4):1212-1233. PubMed ID: 35099487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amplifying "eat me signal" by immunogenic cell death for potentiating cancer immunotherapy.
    Xi Y; Chen L; Tang J; Yu B; Shen W; Niu X
    Immunol Rev; 2024 Jan; 321(1):94-114. PubMed ID: 37550950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanotechnology-enabled immunogenic cell death for improved cancer immunotherapy.
    Li W; Jiang Y; Lu J
    Int J Pharm; 2023 Mar; 634():122655. PubMed ID: 36720448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenic cell death inducers for cancer therapy: An emerging focus on natural products.
    Zhang LL; Zhang DJ; Shi JX; Huang MY; Yu JM; Chen XJ; Wei X; Zou L; Lu JJ
    Phytomedicine; 2024 Sep; 132():155828. PubMed ID: 38905847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tannins in Phyllanthus emblica L. improves cisplatin efficacy in lung cancer cells by boosting endoplasmic reticulum stress to trigger immunogenic cell death.
    Hu Q; Wang S; Cheng R; Liu Y; Chang Z; Huang Y; Chen Y; Luo X; Zhou L; Wang B; Gao Y; Chen H; Liu R; Zhang L
    Phytomedicine; 2024 Jan; 123():155219. PubMed ID: 38056150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioactive Peptide Nanodrugs Based on Supramolecular Assembly for Boosting Immunogenic Cell Death-Induced Cancer Immunotherapy.
    Liu Y; Chang R; Xing R; Yan X
    Small Methods; 2023 May; 7(5):e2201708. PubMed ID: 36720041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In Vitro Veritas: From 2D Cultures to Organ-on-a-Chip Models to Study Immunogenic Cell Death in the Tumor Microenvironment.
    Krysko DV; Demuynck R; Efimova I; Naessens F; Krysko O; Catanzaro E
    Cells; 2022 Nov; 11(22):. PubMed ID: 36429133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multifunctional Nano-Biomaterials for Cancer Therapy via Inducing Enhanced Immunogenic Cell Death.
    Chen Q; Li C; Wang Q
    Small Methods; 2023 May; 7(5):e2201457. PubMed ID: 36703555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomimetic Active Materials Guided Immunogenic Cell Death for Enhanced Cancer Immunotherapy.
    Huang G; Liu L; Pan H; Cai L
    Small Methods; 2023 May; 7(5):e2201412. PubMed ID: 36572642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.